Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Anatomy and Physiology›Cardia
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Cardia

Anatomy and Physiology · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

That part of the stomach close to the opening from esophagus into the stomach (cardiac orifice), the esophagogastric junction.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (1,011 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

That part of the stomach close to the opening from esophagus into the stomach (cardiac orifice), the esophagogastric junction. The cardia is so named because of its closeness to the heart. Cardia is characterized by the lack of acid-forming cells (gastric parietal cells).

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Cardias.

Where it fits in the MeSH classification

Broader topics
Stomach

Related concepts

  • Stomach
  • Esophagus
  • Esophagogastric Junction
  • Heart
  • Gastric Parietal Cells

Research landscape

PubMed indexes 4,596 records tagged with the MeSH heading “Cardia” (counts retrieved 2026-10-31). 243 of them (5.3%) were published from 2020 onward, and the busiest period so far is through 1999 with 2,967 records.

Reviews account for 263 records (5.7%) and meta-analyses for 23. Randomized controlled trials number 54 (1.2%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 2,967 records; 2000-2009: 843 records; 2010-2019: 543 records; 2020 onward: 243 records2,967through 19998432000-20095432010-20192432020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19992,967
2000-2009843
2010-2019543
2020 onward243
Share of records by publication typeReviews: 5.7 percent; Meta-analyses: 0.5 percent; Randomized controlled trials: 1.2 percentReviews5.7% (263)Meta-analyses0.5% (23)Randomized controlled trials1.2% (54)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 4,596 PubMed records
TypeRecordsShare
Reviews2635.7%
Meta-analyses230.5%
Randomized controlled trials541.2%

Method: PubMed query "Cardia"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in anatomy and physiology

Anatomy describes how body structures are built and physiology describes how they normally work, so most findings here are descriptive or mechanistic rather than evidence about treatment. Much of what is known comes from dissection, imaging, tissue studies and experiments in animals, and measurements in healthy volunteers can differ from those in people with disease or at different ages. Normal ranges vary between individuals and populations. Check whether a result was measured in people or in another species, the age and health of the participants, and the method used.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites
Powell J, McConkey CC
1990Research article
Design not recorded in structured metadata
263cc by
PMID 2206952 · DOI · PMC1971432
The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study
Yang L, Kartsonaki C, Yao P, de Martel C, Plummer M, Chapman D, et al.
2021Research article
Design not recorded in structured metadata
165cc by
PMID 34838195 · DOI · PMC8646857
Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia
Haas M, Dimmler A, Hohenberger W, Grabenbauer GG, Niedobitek G, Distel LV
2009Research article
Design not recorded in structured metadata
128cc by
PMID 19732435 · DOI · PMC2749861
Long-term exposure to ambient air pollution and sequential carcinogenesis in the cardia gastric: a cross-sectional study
Zhu J, Tao H, Kang N, Li S, Song L, Li X, et al.
2025Research article
Design not recorded in structured metadata
2cc by
PMID 41430236 · DOI · PMC12750796

Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites [1]

Research article Powell J, McConkey CC · · 1990 · cited 263 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Data in a regional cancer registry covering a population of 5 million and with an efficiency of registration of over 95% have been used to examine incidence trends in oesophageal and gastric carcinoma.
Closing excerpt
The results strongly suggest that the aetiological factors involved for cardia and adjoining sites are different from those for pyloric antrum.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (125 words)

Data in a regional cancer registry covering a population of 5 million and with an efficiency of registration of over 95% have been used to examine incidence trends in oesophageal and gastric carcinoma. In the West Midlands Region of the UK, during the period 1962 to 1981 the age standardised incidence of gastric carcinoma decreased by 20%. However, an analysis by both histological type and detailed site reveals that while the incidence of distal lesions is diminishing, the incidence of adenocarcinoma of the oesophagus and cardia is increasing. The proximal and distal lesions also exhibit marked differences in social class distribution and sex ratio. The results strongly suggest that the aetiological factors involved for cardia and adjoining sites are different from those for pyloric antrum.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 2206952 · DOI · PMC1971432

The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study [2]

Research article Yang L, Kartsonaki C, Yao P, de Martel C, Plummer M, Chapman D, et al. · · 2021 · cited 165 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundHelicobacter pylori infection is a major cause of non-cardia gastric cancer (NCGC), but its causal role in cardia gastric cancer (CGC) is unclear.
Closing excerpt
FundingCancer Research UK, Wellcome Trust, UK Medical Research Council, British Heart Foundation, Kadoorie Charitable Foundation, National Key Research and Development Program of China, and National Natural Science Foundation of China.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (413 words)

BackgroundHelicobacter pylori infection is a major cause of non-cardia gastric cancer (NCGC), but its causal role in cardia gastric cancer (CGC) is unclear. Moreover, the reported magnitude of association with NCGC varies considerably, leading to uncertainty about population-based H pylori screening and eradication strategies in high-risk settings, particularly in China, where approximately half of all global gastric cancer cases occur. Our aim was to assess the associations of H pylori infection, both overall and for individual infection biomarkers, with the risks of NCGC and CGC in Chinese adults.MethodsA case-cohort study was done in adults from the prospective China Kadoorie Biobank study, aged 30-79 years from ten areas in China (Qingdao, Haikou, Harbin, Suzhou, Liuzhou, Henan, Sichuan, Hunan, Gansu, and Zhejiang), and included 500 incident NCGC cases, 437 incident CGC cases, and 500 subcohort participants who were cancer-free and alive within the first two years since enrolment in 2004-08. H pylori biomarkers were measured in stored baseline plasma samples using a sensitive immunoblot assay (HelicoBlot 2.1), with adapted criteria to define H pylori seropositivity. Cox regression was used to estimate adjusted hazard ratios (HRs) for NCGC and CGC associated with H pylori infection. These values were used to estimate the number of gastric cancer cases attributable to H pylori infection in China.FindingsOf the 512 715 adults enrolled in the China Kadoorie Biobank between June, 2004, and July, 2008, 500 incident NCGC cases, 437 incident CGC cases, and 500 subcohort participants were selected for analysis. The seroprevalence of H pylori was 94·4% (95% CI 92·4-96·4) in NGCG, 92·2% (89·7-94·7) in CGC, and 75·6% (71·8-79·4) in subcohort participants. H pylori infection was associated with adjusted HRs of 5·94 (95% CI 3·25-10·86) for NCGC and 3·06 (1·54-6·10) for CGC. Among the seven individual infection biomarkers, cytotoxin-associated antigen had the highest HRs for both NCGC (HR 4·41, 95% CI 2·60-7·50) and CGC (2·94, 1·53-5·68). In this population, 78·5% of NCGC and 62·1% of CGC cases could be attributable to H pylori infection. H pylori infection accounted for an estimated 339 955 cases of gastric cancer in China in 2018.InterpretationAmong Chinese adults, H pylori infection is common and is the cause of large numbers of gastric cancer cases. Population-based mass screening and the eradication of H pylori should be considered to reduce the burden of gastric cancer in high-risk settings.FundingCancer Research UK, Wellcome Trust, UK Medical Research Council, British Heart Foundation, Kadoorie Charitable Foundation, National Key Research and Development Program of China, and National Natural Science Foundation of China.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 34838195 · DOI · PMC8646857

Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia [3]

Research article Haas M, Dimmler A, Hohenberger W, Grabenbauer GG, Niedobitek G, Distel LV · · 2009 · cited 128 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundRecent evidence suggests that CD4+CD25+FoxP3+ regulatory T-cells (Treg) may be responsible for the failure of host anti-tumour immunity by suppressing cytotoxic T- cells.
Closing excerpt
Thus, inhibition of Treg may not be a feasible treatment option in gastric adenocarcinoma.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (187 words)

BackgroundRecent evidence suggests that CD4+CD25+FoxP3+ regulatory T-cells (Treg) may be responsible for the failure of host anti-tumour immunity by suppressing cytotoxic T- cells. We assessed the prognostic significance of tumour infiltrating lymphocytes (TIL) in intestinal-type gastric cardiac cancer.MethodsTumour infiltrating lymphocyte (TIL) subsets and tumour infiltrating macrophages (TIM) were investigated in 52 cases using tissue microarrays. The interrelationship between the cell populations (CD3+, CD8+, CD20+, CD68+, GranzymeB+, FoxP3+) in different compartments and NED-survival was investigated (median follow-up time: 61 months).ResultsIntraepithelial infiltration with TIL and TIM including Treg was generally low and not related to NED-survival. However, patients with large numbers of FoxP3+ Treg in the tumour stroma (>125.9 FoxP3+TILs/mm2) had a median survival time of 58 months while those with low FoxP3+ TIL counts (ConclusionOur results suggest that inflammatory processes within the tumour stroma of gastric intestinal-type adenocarcinomas located at the gastric cardia may affect outcome in two ways. Tumour-infiltrating macrophages are likely to promote carcinogenesis while large numbers of Treg are associated with improved outcome probably by inhibiting local inflammatory processes promoting carcinogenesis. Thus, inhibition of Treg may not be a feasible treatment option in gastric adenocarcinoma.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 19732435 · DOI · PMC2749861

Long-term exposure to ambient air pollution and sequential carcinogenesis in the cardia gastric: a cross-sectional study [4]

Research article Zhu J, Tao H, Kang N, Li S, Song L, Li X, et al. · · 2025 · cited 2 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundCardia gastric cancer (CGC) is a distinct and increasingly prevalent malignancy, yet the role of air pollution in its sequential carcinogenesis remains unclear.
Closing excerpt
ConclusionsLong-term exposure to air pollutants is associated with the progression of cardia gastric lesions, highlighting the importance of incorporating air quality improvement into cancer prevention strategies.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (286 words)

BackgroundCardia gastric cancer (CGC) is a distinct and increasingly prevalent malignancy, yet the role of air pollution in its sequential carcinogenesis remains unclear. The present cross-sectional study aimed to evaluate the associations between long-term exposure to ambient air pollution and the progression of precancerous cardia gastric lesions.MethodsA total of 99,493 participants were enrolled from the National Opportunistic Screening Program for Upper Gastrointestinal Cancer in Zhejiang Province of China from 2022 to 2023. Long-term exposure to six air pollutants including particulate matter (PM10), fine particulate matter (PM2.5), sulfur dioxide (SO2), nitrogen dioxide (NO2), ozone (O3), and carbon monoxide (CO) was assessed by using ChinaHighAirPollutants (CHAP) dataset. Cardia lesion progression was classified into five histopathological stages based on endoscopic biopsy. Ordinal logistic regression was used to examine pollutant-specific associations, restricted cubic splines (RCS) were applied to assess the potential exposure-response associations, and weighted quantile sum (WQS) regression was performed to evaluate the mixture effects.ResultsAll six pollutants were significantly associated with cardia lesion progression. The adjusted odds ratios (95% confidence intervals, 95% CI) per standard deviation increment in 5-year mean concentration were 1.21 (1.17-1.25) for PM10, 1.28 (1.23-1.32) for PM2.5, 1.17 (1.13-1.21) for SO2, 1.07 (1.03-1.10) for NO2, 1.16 (1.12-1.20) for O3, and 1.36 (1.30-1.41) for CO. RCS analyses indicated non-linear exposure-response patterns for NO2, O3, and CO. In mixture models, CO and PM2.5 were identified as the predominant contributors, with a 10% increase in combined exposure associated with a 10% (95% CI: 7-13%) higher risk of cardia lesion progression. Effect modification analysis revealed that Helicobacter pylori-positive individuals were more susceptible to pollution-related progression.ConclusionsLong-term exposure to air pollutants is associated with the progression of cardia gastric lesions, highlighting the importance of incorporating air quality improvement into cancer prevention strategies.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41430236 · DOI · PMC12750796

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Gastric cancer: epidemiology and risk factors [5]
    de Martel C, Forman D, Plummer M · Gastroenterol Clin North Am · 2013 · cited 261 times (Europe PMC)
  • Research article Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification [6]
    Siewert JR, Feith M, Stein HJ · J Surg Oncol · 2005 · cited 151 times (Europe PMC)
  • Research article Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment [7]
    DeMeester SR · Ann Surg Oncol · 2006 · cited 147 times (Europe PMC)
  • Research article A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma [8]
    Turati F, Tramacere I, La Vecchia C, Negri E · Ann Oncol · 2013 · cited 140 times (Europe PMC)
  • Research article Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis [9]
    Cavaleiro-Pinto M, Peleteiro B, Lunet N, Barros H · Cancer Causes Control · 2011 · cited 135 times (Europe PMC)
  • Research article Per-oral endoscopic myotomy white paper summary [10]
    NOSCAR POEM White Paper Committee, Stavropoulos SN, Desilets DJ, Fuchs KH, Gostout CJ, Haber G, et al. · Gastrointest Endosc · 2014 · cited 108 times (Europe PMC)

References

  1. Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. . 1990. PMID 2206952 · DOI · PMC1971432
  2. Yang L, Kartsonaki C, Yao P, de Martel C, Plummer M, Chapman D, et al.. The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study. . 2021. PMID 34838195 · DOI · PMC8646857
  3. Haas M, Dimmler A, Hohenberger W, Grabenbauer GG, Niedobitek G, Distel LV. Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia. . 2009. PMID 19732435 · DOI · PMC2749861
  4. Zhu J, Tao H, Kang N, Li S, Song L, Li X, et al.. Long-term exposure to ambient air pollution and sequential carcinogenesis in the cardia gastric: a cross-sectional study. . 2025. PMID 41430236 · DOI · PMC12750796
  5. de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am. 2013. PMID 23639638 · DOI
  6. Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol. 2005. PMID 15895452 · DOI
  7. DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol. 2006. PMID 16378161 · DOI
  8. Turati F, Tramacere I, La Vecchia C, Negri E. A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. Ann Oncol. 2013. PMID 22898040 · DOI
  9. Cavaleiro-Pinto M, Peleteiro B, Lunet N, Barros H. Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control. 2011. PMID 21184266 · DOI
  10. NOSCAR POEM White Paper Committee, Stavropoulos SN, Desilets DJ, Fuchs KH, Gostout CJ, Haber G, et al.. Per-oral endoscopic myotomy white paper summary. Gastrointest Endosc. 2014. PMID 24950639 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Esophagogastric JunctionAnatomy and Physiology
  • StomachAnatomy and Physiology
  • EsophagusAnatomy and Physiology
  • Gastric FundusAnatomy and Physiology
  • Gastric MucosaAnatomy and Physiology
  • Esophageal MucosaAnatomy and Physiology

All 542 articles in Anatomy and Physiology →

At a glance

4,596
PubMed records on this heading
5%
published since 2020
263
review articles
54
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Esophagogastric JunctionAnatomy and Physiology
  • StomachAnatomy and Physiology
  • EsophagusAnatomy and Physiology
  • Gastric FundusAnatomy and Physiology
  • Gastric MucosaAnatomy and Physiology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support